The 2 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 48.00, with a high estimate of 62.00 and a low estimate of 34.00. The median estimate represents a +47.06% increase from the last price of 32.64.
The current consensus among 3 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since July, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.15
Reporting Date Nov 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.